Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 21 » default
ISSN: 1178-2021
- View all (4447)
- Volume 21, 2025 (113)
- Volume 20, 2024 (228)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 21, 2025
- default (113)
- The effectiveness of non-pharmacological interventions for people with cognitive dysfunction (2)
- Advanced Neurorestoratology: Basic and Clinical Research (2)
- Closing the Mortality Gap: Novel Approaches to Improve Physical Health and Quality of Life among People with Mental Illness (2)
An Effectiveness Trial of an Exercise Physiologist Service to Improve Quality of Life in Adults with Severe Mental Illness: Protocol for the MOVEMENT Study
Chapman JJ, Siskind D, Yung AR, Lee YY, Arnautovska U, Scott JG, Burke K, Malacova E, Korman N, Wyder M, Doohan MA, Keating SE, Parker S, Walker ME, Hu D, O’Brien J, Lau G, Pratt GF, Rosenbaum S, Curtis J, Chatterton ML, Simmons L, Wheeler AJ
Neuropsychiatric Disease and Treatment 2025, 21:1399-1408
Published Date: 11 July 2025
Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-Release Tablets on Somatic Symptoms of Major Depressive Disorder: A Prospective, Single-Arm, Multicenter Clinical Study
Wang Y, He M, Zhang H, Luo Y, Sun X, Yao Z, Tang H, Yan R, Du X, Li Z, Peng D, Wang Z
Neuropsychiatric Disease and Treatment 2025, 21:1387-1397
Published Date: 9 July 2025
Prevalence, Diagnosis, and Treatment of Generalized Anxiety Disorder in Working Individuals: A Cross-Sectional Study Using Health Claims and Survey Data in Japan
Matsuyama S, Otsubo T, Nomoto K, Misago R, Higa S
Neuropsychiatric Disease and Treatment 2025, 21:1371-1385
Published Date: 9 July 2025
Nomogram Model for Predicting Risk of Postoperative Delirium in Adult Liver Transplant Patients: A Retrospective Study
Yu LL, Gong Y, Fang F, Wang T, Cang J
Neuropsychiatric Disease and Treatment 2025, 21:1359-1369
Published Date: 8 July 2025
Clinical Efficacy of Mind-Regulating Acupuncture on Post-Stroke Depression Based on the “Microbiota-Gut-Brain Axis” Theory: A Randomized Controlled Study
Xie J, Li J, Sun Q, Jiang J
Neuropsychiatric Disease and Treatment 2025, 21:1349-1358
Published Date: 7 July 2025
A Clinical-Metabolic Prediction Model for Suicidal Behaviors Risk Stratification in First-Admission Major Depressive Disorder: A Cross-Sectional Analysis
Geng L, Zhang S, Yan J, Wang R
Neuropsychiatric Disease and Treatment 2025, 21:1339-1348
Published Date: 5 July 2025
Accuracy of Death Certificates in Attributing Mortality to Alzheimer’s Disease and Other Dementias in Japanese Psychiatric Hospitals
Sato K, Shioda K, Suda S
Neuropsychiatric Disease and Treatment 2025, 21:1325-1337
Published Date: 5 July 2025
Evaluating the Therapeutic Efficacy of rTMS Combined with Low-Dose Antipsychotic Medication in Somatic Symptom Disorder
Wu J, Wang T, Jiang X
Neuropsychiatric Disease and Treatment 2025, 21:1315-1324
Published Date: 3 July 2025
Blood Uric Acid in Mild Cognitive Impairment: A Cross-Sectional Study of Older Chinese Adults
Xue L, Xiao X, Mao X, Zhang X, Liu Y, Wu B
Neuropsychiatric Disease and Treatment 2025, 21:1307-1314
Published Date: 28 June 2025
A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMART
Arnautovska U, Ritchie G, Soole R, Menon A, Korman N, Milton A, Varnfield M, Kelly JT, Jansen PM, Baker A, Ireland D, Russell AW, Chapman J, Mulligan K, Hirani SP, Vitangcol KJ, McKeon G, Siskind D
Neuropsychiatric Disease and Treatment 2025, 21:1289-1305
Published Date: 26 June 2025
Earlier Use of Long-Acting Injectable Paliperidone Palmitate Once-Monthly versus Oral Antipsychotics in Patients with Schizophrenia: An Integrated Patient-Level Meta Analysis of the PROSIPAL and PRIDE Studies [Corrigendum]
Sajatovic M, Doring M, Lopena OJ, Johnston K, Turkoz I, Josiah N, Obando C
Neuropsychiatric Disease and Treatment 2025, 21:1287-1288
Published Date: 27 June 2025
Auditory N1, N2, and MMN to Pure-Tone and Consonant–Vowel Stimuli in Developmental Dyslexia and Benign Rolandic Epilepsy: A Progressive Insight Into the Underlying Disruptive Neurophysiology
Tomé D, Pereira I, Vieira MC, Soares AP, Barbosa F
Neuropsychiatric Disease and Treatment 2025, 21:1271-1286
Published Date: 25 June 2025
Severity and Prognosis of Vascular Dementia in Patients with Acute Cerebral Infarction Combined with H-Type Hypertension and Its Correlation with Uric Acid Levels
Hong Y, Feng M
Neuropsychiatric Disease and Treatment 2025, 21:1261-1270
Published Date: 24 June 2025
Effects of Binaural Beat Music and Esketamine for ECT in the Treatment of Major Depressive Disorder: A Randomized Controlled Trial Protocol
Zhang Y, Ke Z, Luo J, Chen Q, Xu X, Jiang X, Xiong J
Neuropsychiatric Disease and Treatment 2025, 21:1249-1260
Published Date: 24 June 2025
An Evaluation a PrEP-Focused HIV Prevention Intervention Tailored for Individuals with Opioid Use Disorder and Cognitive Dysfunction
Mistler CB, Huedo-Medina TB, Shrestha R, Gunstad J, Zelenev A, Copenhaver MM
Neuropsychiatric Disease and Treatment 2025, 21:1235-1248
Published Date: 24 June 2025
Traditional Chinese Medicine in the Management of Anxiety Disorders: A Narrative Review of Theoretical Foundations, Clinical Applications, and Modern Integrative Approaches
Wang Q, Wang D, Lv Y, Li Q
Neuropsychiatric Disease and Treatment 2025, 21:1215-1233
Published Date: 18 June 2025
Long-Term Symptomatic and Functional Remission with Paliperidone Palmitate 6-Monthly Treatment in Schizophrenia: A 3-Year Post-Hoc Analysis
Hamilton JM, Johnston KL, Simples Jnr J, Turkoz I, Lim L, Antunes J, Obando C, Mattingly G
Neuropsychiatric Disease and Treatment 2025, 21:1203-1214
Published Date: 18 June 2025
Effects of Parental Attitudes in Childhood on Depressive Symptoms Through Trait Anxiety and Negative Life Events in Adult Volunteers
Hayashida T, Kikkawa M, Masuya J, Ono M, Ito S, Nibuya R, Takashio O, Tamada Y, Hashimoto N, Inoue T
Neuropsychiatric Disease and Treatment 2025, 21:1191-1201
Published Date: 15 June 2025
Human Neural Stem Cells Reduce Hypoxia-Ischemic Neurological Impairment Through the Regulation of Inflammatory M1/M2 Microglias in Rats
Ding YB, Zhao Y, Chen BY, Wang Q, Wang ZY, Luan Z, Yi B
Neuropsychiatric Disease and Treatment 2025, 21:1173-1190
Published Date: 9 June 2025
Dynamic Changes in ALFF and DC in Subthreshold Depression Before and After ICBT Intervention
Wang Y, Ying Y, Zhu Z, Wang L, Yang Y, Zhang L, Yu W, Liang Y, Zhang H, Ji Y, Pan Y
Neuropsychiatric Disease and Treatment 2025, 21:1161-1172
Published Date: 7 June 2025
Association Between Daytime Sleepiness and Quality of Life in Chinese Adolescents: A Moderated Mediation of Cognitive Dysfunction and Depressive Symptoms
Li W, Hu N, Yang X, Zheng W, Tong J, Song J, Song Y, Gao X, Wang Z, Liu W, Wang L, Tan Y, Wang C, Deng H
Neuropsychiatric Disease and Treatment 2025, 21:1143-1159
Published Date: 3 June 2025
Effects of Intelligence Levels and Autistic Severity on Adaptive Functioning and Cognitive-Adaptive Functioning Gaps in School-Aged Children with Autism Spectrum Disorder
Jin WY, Song C, Wang YY, Liu XL, Li WH, Wu LL, Zhu ZW
Neuropsychiatric Disease and Treatment 2025, 21:1131-1142
Published Date: 4 June 2025
Auto-Immune Glial Fibrillary Acidic Protein Astrocytopathy with Active Intrathecal Epstein-Barr Virus: A Single-Center Case Series Report
Yu X, Zou Y, Li M, Wang L, Feng W, Wei L, Yang L, He J, Bu H, Li Y
Neuropsychiatric Disease and Treatment 2025, 21:1119-1130
Published Date: 31 May 2025
Alterations in White Matter Structure in Sleep-Related Epilepsies: A TBSS-Based Diffusion Tensor Imaging Study
Wang Z, Liu W, Feng X, Wang Q, Ning X, Xing W
Neuropsychiatric Disease and Treatment 2025, 21:1109-1118
Published Date: 30 May 2025
Methodological Considerations in Humidex and Schizophrenia Research [Letter]
Zubaidah T, Sofia N
Neuropsychiatric Disease and Treatment 2025, 21:1107-1108
Published Date: 23 May 2025
Network Analysis of Anxiety, Insomnia, Depression, and Suicide Attempts in Chinese Outpatients with Somatic Symptom Disorder
Fang J, Tang H, Liao H, Zhong Y, Li Y, Liao Y, Li Y
Neuropsychiatric Disease and Treatment 2025, 21:1091-1105
Published Date: 22 May 2025
Machine Learning Based Early Diagnosis of ADHD with SHAP Value Interpretation: A Retrospective Observational Study
Zhang X, Xiao X, Luo Y, Xiao W, Cao Y, Chang Y, Wu D, Xu H, Zhao J, Deng X, Jiang Y, Xie R, Liu Y
Neuropsychiatric Disease and Treatment 2025, 21:1075-1090
Published Date: 21 May 2025
Alterations of Blood Plasma Metabolites, Including Kynurenine and Tryptophan, in Bipolar Disorder
Nakayama T, Umehara H, Mawatari K, Tomioka Y, Yoshida T, Matsuda H, Matsumoto Y, Masuda R, Kamishikiryo T, Fuchikami M, Nakataki M, Takahashi A, Tajima A, Okada G, Numata S
Neuropsychiatric Disease and Treatment 2025, 21:1067-1073
Published Date: 18 May 2025
The Roles of Heart Rate Variability in Cerebral Stroke
Wang H, Jiang J, Zhou G, Zhang Y
Neuropsychiatric Disease and Treatment 2025, 21:1057-1065
Published Date: 16 May 2025
Aripiprazole Lauroxil Every 2 Months or Paliperidone Palmitate Monthly for Acute Schizophrenia: A Post Hoc Analysis of PANSS Five-Factor Scores in the ALPINE Trial
Citrome L, Dunbar M, McGrory JA
Neuropsychiatric Disease and Treatment 2025, 21:1047-1055
Published Date: 14 May 2025
Efficacy and Tolerability of Viloxazine Compared to Placebo on Emotional, Behavioral, and Executive Functioning in Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis
Maneeton P, Maneeton B, Winichaikul Y, Kawilapat S, Kienngam N, Maneeton N
Neuropsychiatric Disease and Treatment 2025, 21:1029-1045
Published Date: 12 May 2025
Association Between Health-Related Physical Fitness and Depressive Symptoms in Chinese Adolescents: A Nationwide Cross-Sectional Study Under the Healthy China Initiative
Cao YB
Neuropsychiatric Disease and Treatment 2025, 21:1019-1027
Published Date: 9 May 2025
The Correlation Between DRD2 and COMT Gene Polymorphisms, HPT and HPG Axes Functions, and Antipsychotic Drug-Induced Hyperprolactinemia and Macroprolactinemia
Wang Z, Li J, Chen H, Jin H, Wang S, Hu X
Neuropsychiatric Disease and Treatment 2025, 21:1011-1017
Published Date: 8 May 2025
Potential Value of Plasma-Based Biomarkers for Prediction of Episodic Memory Performance and Identification of Individuals with Amnestic Mild Cognitive Impairment
Wang M, Zhang Z, Shi Y, Shu H, Xie C, Ren Q, Wang Z
Neuropsychiatric Disease and Treatment 2025, 21:999-1010
Published Date: 5 May 2025
Association of Exposure to Humidex with Schizophrenia Admissions in Qingdao, China: A Time-Series Study
Han H, Liu J, Wang L, Li G, Wang T
Neuropsychiatric Disease and Treatment 2025, 21:989-997
Published Date: 29 April 2025
Altered Gut Microbiota and Plasma Metabolome Profiles Characterize Depression Individuals with Ischemic Stroke: A Comparative Analysis
Cao N, Lv D, Liu Y, Zhang H, Zhang X
Neuropsychiatric Disease and Treatment 2025, 21:973-987
Published Date: 29 April 2025
Potential Inflammatory Biomarkers and Differential Gut Microbiota in Cognitive Impairment After Ischemic Stroke
Wu L, Jiang Y, Xu W, Wang L, Li L, Zhang C, Huang K, Yang Y, Dai J, Zhou F
Neuropsychiatric Disease and Treatment 2025, 21:965-972
Published Date: 28 April 2025
Beyond Anxiety and Depression: Multidimensional Psychiatric Screening for Neurological Patients Based on HADS and BSI-53
Kujovic M, Benz D, Baumann B, Engelke C, Margittai Z, Christl J, Seitz RJ, Menge T, Bahr C, Riesbeck M, Meisenzahl E, Schmidt-Kraepelin C
Neuropsychiatric Disease and Treatment 2025, 21:955-964
Published Date: 26 April 2025
Associations of Vocal Features, Psychiatric Symptoms, and Cognitive Functions in Schizophrenia
Natsuyama T, Chibaatar E, Shibata Y, Okamoto N, Cruz Victorino JN, Ikenouchi A, Shibata T, Yoshimura R
Neuropsychiatric Disease and Treatment 2025, 21:943-954
Published Date: 23 April 2025
Exploration of Epigenetic Mechanisms and Biomarkers Among Patients with Very-Late-Onset Schizophrenia-Like Psychosis
Gan Y, Yue W, Sun J, Yang D, Fang C, Zhou Z, Yin J, Zhou H
Neuropsychiatric Disease and Treatment 2025, 21:927-942
Published Date: 22 April 2025
Clinical Efficacy of Acupuncture Combined with Escitalopram Oxalate in the Treatment of Mild-to-Moderate Post-Stroke Depression
Liu Y, Zhang G, Li J, Lv Y, Qi R
Neuropsychiatric Disease and Treatment 2025, 21:917-925
Published Date: 17 April 2025
An Event-Related Potential Study on Facial Recognition in Children with and without Autism Spectrum Disorders
Deng JR, Tong M, Zhang XT, Lin ZP, Wang Z, Long J, Chen ZM
Neuropsychiatric Disease and Treatment 2025, 21:903-916
Published Date: 15 April 2025
Association Between the Time of Exposure to Electronic Screen and Anxiety and Depression After Controlling Demographics, Exercises, and Lifestyles Among University Students
Zhang L, Zhao S, Zhao S, Ke Y, Yang W, Lei M
Neuropsychiatric Disease and Treatment 2025, 21:885-902
Published Date: 15 April 2025
Prevalence and Associated Factors of Depression in Patients with Ischaemic Stroke: A Cross-Sectional Study
Li Y, Qin W, Chen Y, Zhang D, Zhao Y
Neuropsychiatric Disease and Treatment 2025, 21:875-883
Published Date: 14 April 2025
The 4977 Bp Deletion of Mitochondrial DNA as a Potential Trait Marker for Major Depressive Disorder
He Y, Yang X, Li Z, Liu W, Tang J, Chen X
Neuropsychiatric Disease and Treatment 2025, 21:867-873
Published Date: 13 April 2025
Biomarkers of Suicidal Ideation in Depression: Insights From VMHC Analysis and Machine Learning
Wang X, Liu F, Hu X, Zhang Q, Guan X, Wu J, Long X, Lu Z
Neuropsychiatric Disease and Treatment 2025, 21:855-865
Published Date: 13 April 2025
Impact of Emotional Blunting on Patient Social Function and Depressive Symptoms: A Post Hoc Analysis of a Web-Based Survey in Japanese Patients with Major Depressive Disorder
Kikuchi T, Iga JI, Hattori A, Tokuda F, Moriguchi Y, Hoshino T
Neuropsychiatric Disease and Treatment 2025, 21:841-854
Published Date: 12 April 2025
Correlation Between Systemic Immune Inflammatory Index and Suicidal Attempt in Patients with First-Episode Untreated Depression and its Risk Factors
Wu Y, Jiang W, Chen M, Jiang Q, Huang H, Guo W, Yuan Y
Neuropsychiatric Disease and Treatment 2025, 21:827-839
Published Date: 11 April 2025
Ascorbic Acid and Esketamine for Mental Disorders in Women with Miscarriage: A Randomized Controlled Double-Blind Trial Protocol
Ke Z, Zhang Y, Cai B, Luo J, Ma Y, Chen Q, Deng L
Neuropsychiatric Disease and Treatment 2025, 21:815-825
Published Date: 11 April 2025
Acupuncture Ameliorates Alzheimer’s-Like Cognitive Impairment and Pathological Changes via Regulating the Intestinal Fungal Community in APP/PS1 Mice
Hao X, Ding N, Zhang Y, Wu M, Tao Y, Li Z
Neuropsychiatric Disease and Treatment 2025, 21:799-813
Published Date: 9 April 2025
Disruption of Multimodal Brain Networks and Structural-Functional Coupling in Adolescents with Major Depressive Disorder
Wang Y, Wei J, Yan Y, Wang M, Fan H, Du Y, Yang X, Ma X, Ma X
Neuropsychiatric Disease and Treatment 2025, 21:791-798
Published Date: 9 April 2025
Dyadic Effects of Stigma and Self-Compassion on Resilience of Schizophrenic Patients and Caregivers During Recovery: An Actor-Partner Interdependence Mediation Model
Feng J, Du C, Xiao Y, Liu J, Chen Q, Liu Y, Zhang Z
Neuropsychiatric Disease and Treatment 2025, 21:775-790
Published Date: 8 April 2025
Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed
Citrome L, Neugebauer NM, Meli AA, Kando J
Neuropsychiatric Disease and Treatment 2025, 21:761-773
Published Date: 5 April 2025
Psychological Disturbances and Associated Risk Factors in Chinese Mine Rescuers: A Cross-Sectional Study
Hou Y, Meng Y, Wu F, Yang S, Yang F
Neuropsychiatric Disease and Treatment 2025, 21:751-760
Published Date: 5 April 2025
Relationship Between Peritraumatic Dissociation, Beliefs About Losing Control, Resilience, and PTSD on Earthquake Survivors in Turkey
Unal GA, Kocatepe Avcı U, Ozdemir E
Neuropsychiatric Disease and Treatment 2025, 21:741-750
Published Date: 5 April 2025
An Alternative Approach to Future Diagnosis: Can Generalized Anxiety Disorder Be Distinguished From Major Depressive Disorder, Healthy People by Differentially Expressed lncRNAs in Peripheral Blood
Kong L, Zhang L
Neuropsychiatric Disease and Treatment 2025, 21:729-739
Published Date: 4 April 2025
Exogenous GABA Alleviates Tourette Syndrome-Like Behavior in Sprague-Dawley Rats by Altering Gut Microbiota and Striatum Metabolism
Xu Y, Li LN, He XJ, Wang S, Li X, Feng H, Zhang HF, Song L, Shi HS, Tian XY
Neuropsychiatric Disease and Treatment 2025, 21:711-727
Published Date: 4 April 2025
Functional and Structural Network Alterations in HIV-Associated Asymptomatic Neurocognitive Disorders: Evidence for Functional Disruptions Preceding Structural Changes
Zhou Z, Gong W, Hu H, Wang F, Li H, Xu F, Li H, Wang W
Neuropsychiatric Disease and Treatment 2025, 21:689-709
Published Date: 1 April 2025
Genotypic and Phenotypic Characteristics of Pediatric X-Adrenoleukodystrophy in a Chinese Cohort
Zhang Y, Shi X, Huang J, Wang C, Wu S, Tian G, Jia J, Chen Y
Neuropsychiatric Disease and Treatment 2025, 21:677-687
Published Date: 27 March 2025
Direct and Indirect Effects of Risk Perception and Risk Information on PTSD in Frontline Healthcare Workers
Wu L, Geng S, Zhou Y, Jiao R, Ouyang H, Cheng S, Shang Z, Yan W, Wang J, Jia Y, Li X, Liu W
Neuropsychiatric Disease and Treatment 2025, 21:663-676
Published Date: 21 March 2025
Anxiolytic, Antidepressant and Healthy Sleep-Promoting Potential of Rosmarinic Acid: Mechanisms and Molecular Targets
Priya V, Srinivasan D, Priyadarsini S, Dabaghzadeh F, Rana SS, Chengaiyan JG, Sudesh R, Ahmad F
Neuropsychiatric Disease and Treatment 2025, 21:641-661
Published Date: 20 March 2025
Feasibility of Serum Peroxiredoxin 2 as a Biochemical Indicator for Reflecting Severity and Prognosticating Stroke-Associated Pneumonia, Early Neurological Deterioration and Poor Neurological Outcomes in Acute Supratentorial Intracerebral Hemorrhage: An Observational Analytical Clinical Study
Zhang C, Zhang G, Ye Z, Hu G, Ge S, Luo K, Li Z
Neuropsychiatric Disease and Treatment 2025, 21:621-640
Published Date: 20 March 2025
A Pilot Study of Remote Ischemic Conditioning in Preventing Post-Stroke Depression
Li W, Qin Y, Wang J, Li L, Gao J, Xu X, Wu Z, Ji X, Wang Y, Gao K, Ren M, Shao X
Neuropsychiatric Disease and Treatment 2025, 21:611-619
Published Date: 19 March 2025
Inconsistent Cognitive Assessment Criteria in PD-MCI Research [Letter]
Wang J
Neuropsychiatric Disease and Treatment 2025, 21:609-610
Published Date: 19 March 2025
The Association Between Antidepressant Treatment and Heart Rate Deceleration Capacity in Patients With Mood disorders—A Potential New Predictor of Sudden Cardiac Death
Okayasu H, Sugawara N, Fujii K, Ozeki Y, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2025, 21:597-607
Published Date: 18 March 2025
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia
Citrome L, Correll CU, Cutler AJ, Dunbar M, Hoberg AR, Hopkinson C, Mattingly GW, McGrory JA, Rege B, Weiden PJ, McDonnell D
Neuropsychiatric Disease and Treatment 2025, 21:575-596
Published Date: 14 March 2025
Exploring Gender Differences in the Relationship Between Thyroid Function and Aggressive and Impulsive Behaviors in Patients with Major Depressive Disorder
Zhao S, Wang A, Han Y, Song C, Zhang H, He K, Chen J
Neuropsychiatric Disease and Treatment 2025, 21:563-574
Published Date: 14 March 2025
Transdiagnostic Effects of Schizophrenia Polygenic Scores on Treatment Outcomes in Major Psychiatric Disorders
Serretti A, Baune BT
Neuropsychiatric Disease and Treatment 2025, 21:547-562
Published Date: 13 March 2025
Environmental Factors in the Etiology of Mental Disorders in the Czech Republic: Final Results
Hosak L, Hurdova K, Hrnciarova J, Zapletalova J, Koncelikova D, Latalova K
Neuropsychiatric Disease and Treatment 2025, 21:541-545
Published Date: 12 March 2025
Predictive Value of NT-proBNP for Functional Outcome of Ischemic Stroke Without Cardiac Disease: A Prospective, Observational Study [Corrigendum]
Liu R, Chen G, Zhao N, Yue W
Neuropsychiatric Disease and Treatment 2025, 21:539-540
Published Date: 10 March 2025
A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis
Li M, Bai Y, Wang Y, Xing H, Zhang Y, Ding W, Ye H, Ma L, Wang W, Bao T
Neuropsychiatric Disease and Treatment 2025, 21:525-538
Published Date: 7 March 2025
The Correlation Between RIN3 Gene Methylation and Cognitive Impairment in Parkinson’s Disease
Yu X, Zhu K, Wang T, Li HY, Zhang X, Zhong X, Wang L
Neuropsychiatric Disease and Treatment 2025, 21:511-524
Published Date: 7 March 2025
Duration Mismatch Negativity in Adults With Autism Spectrum Disorder Versus Healthy Controls
Sato A, Itagaki S, Ohnishi T, Osakabe Y, Hoshino H, Kanno K, Suzutani K, Wada T, Miura I, Yabe H
Neuropsychiatric Disease and Treatment 2025, 21:503-510
Published Date: 5 March 2025
Optimal Treatment of Magnetic Seizure Therapy (MST) in Patients with Clozapine-Resistant Schizophrenia (CRS)
Xiang Q, Xu P, Zhai Z, Jia Y, Li C, Liu D
Neuropsychiatric Disease and Treatment 2025, 21:491-501
Published Date: 5 March 2025
Characteristics of Gut Microbiota and Plasma Metabolites in Patients with Post-Stroke Depression
Yan C, Si T, Zheng W, Huang L, Wen L, Shen H, Qu M
Neuropsychiatric Disease and Treatment 2025, 21:477-489
Published Date: 4 March 2025
The Prevalence of Tardive Dyskinesia In Patients With Schizophrenia Treated With Antipsychotics In Malaysia
Nedunjelian A, Ng CG, Lim PK, Sulaiman AH, Koh OH, Francis B
Neuropsychiatric Disease and Treatment 2025, 21:465-475
Published Date: 5 March 2025
Neuropsychiatric Disease and Treatment: 20 Years on
Pinder RM
Neuropsychiatric Disease and Treatment 2025, 21:463-464
Published Date: 1 March 2025
Neuropsychiatric Approaches to Essential and Functional Tremor: A Comparative Study
Balal M, Çakmak S, Erdem M, Demirkiran M
Neuropsychiatric Disease and Treatment 2025, 21:451-462
Published Date: 2 March 2025
Uncovering Potential Biomarkers and Constructing a Prediction Model Associated with Iron Metabolism in Parkinson’s Disease
Cheng Y, Zhai H, Liu Y, Yang Y, Fang B, Song M, Zhong P
Neuropsychiatric Disease and Treatment 2025, 21:437-449
Published Date: 28 February 2025
Preclinical Evidence for the Use of Brexpiprazole + Antidepressant Treatment for Major Depressive Disorder and Post-Traumatic Stress Disorder: A Systematic Review
Brubaker M, Kapadia S, Maletic V, Chambers JS, Watling CP, Citrome L
Neuropsychiatric Disease and Treatment 2025, 21:421-436
Published Date: 28 February 2025
Activation of the Reelin/GSK-3β/p-Tau Signaling Pathway in the Hippocampus of Patients with Temporal Lobe Epilepsy
Lin J, Lin X, Fu YJ, Li X, Li X, Wang Y, Zhao L, Yu S, Piao YS
Neuropsychiatric Disease and Treatment 2025, 21:409-419
Published Date: 27 February 2025
Understanding Relapse in Bipolar Disorder at a Tertiary Mental Health Facility in Uganda
Kimbowa P, Nalwoga V, Namwanje S, Ssekulima JK, Anguparu SW
Neuropsychiatric Disease and Treatment 2025, 21:395-408
Published Date: 27 February 2025
Examination on the Acceptability, Feasibility and Effectiveness of a Digital Cognitive Training Software in Patients With Stable Schizophrenia in China
Yang L, Tang Y, Zhu J, Xu L, Wang M, Sun W, Shi C
Neuropsychiatric Disease and Treatment 2025, 21:383-393
Published Date: 27 February 2025
Correlation Between Monocyte Count, Monocyte–Lymphocyte Ratio, and Other Inflammatory Cells With Sleep and Psychiatric Symptoms in First-Episode Schizophrenia Patients
Hu C, Du N, Li J, Chen L, Meng X, Yao L, Yu T, Shi L, Zhang X
Neuropsychiatric Disease and Treatment 2025, 21:373-381
Published Date: 26 February 2025
Fibroblast Growth Factor 21 Protects Against Cerebral Ischemia/Reperfusion Injury by Inhibiting Oxidative Stress and Ferroptosis
Li J, Jiang H, Bai W, Yang Y, Zhou G, Chen W, Shao J
Neuropsychiatric Disease and Treatment 2025, 21:355-371
Published Date: 25 February 2025
Prevalence and Correlates of Diurnal Mood Variation in Chinese Adolescents with Major Depressive Disorder and Anxiety Symptoms: A Cross-Sectional Study
Duan J, Zhang Y, Tao J, Fan X
Neuropsychiatric Disease and Treatment 2025, 21:347-353
Published Date: 21 February 2025
Association of Blood Pressure with Neurological Function Decline and Functional Outcome in Patients of Watershed Infarction
Yang L, Zhang T, Liu X, Chen G, Ding P, Li W, Liao H, Yu D, Liu J, Yue W
Neuropsychiatric Disease and Treatment 2025, 21:335-346
Published Date: 19 February 2025
Efficacy of Magnetic Seizure Therapy in Patients with Schizophrenia and Combined fMRI-EEG to Explore the Regulatory Mechanisms of Brain Networks
Wei S, Chen B, Guo Z, Zhang H, Li J, Hu X, Yang C, Li J, Li X, Liu Z, Xu Y, Liu S
Neuropsychiatric Disease and Treatment 2025, 21:323-334
Published Date: 19 February 2025
Study on the Molecular Mechanism of Baicalin Phosphorylation of Tau Protein Content in a Cell Model of Intervention Cognitive Impairment
Li J, Zhao C, Guan D, Liu C
Neuropsychiatric Disease and Treatment 2025, 21:309-322
Published Date: 19 February 2025
Usefulness of Serum NOX4 as a Potential Biomarker to Predict Early Neurological Deterioration and Poor Outcome of Spontaneous Intracerebral Hemorrhage: A Prospective Observational Study
Wu X, He H, Shen D, Ye X, Chen Z, Zou S, Zhou K, Ye X, Zhang Z, Li H, Liu J
Neuropsychiatric Disease and Treatment 2025, 21:295-307
Published Date: 19 February 2025
Modulating Gut Microbiota: The Mechanism of Electroacupuncture at the “Siguan” Acupoints in Alleviating Post-Stroke Depression
Li Z, Li L, Xu H, Kang Z, Shi X, Zhang P, Ye H
Neuropsychiatric Disease and Treatment 2025, 21:281-294
Published Date: 14 February 2025
Electroencephalogram (EEG) Based Prediction of Attention Deficit Hyperactivity Disorder (ADHD) Using Machine Learning
Kim JW, Kim BN, Kim JI, Yang CM, Kwon J
Neuropsychiatric Disease and Treatment 2025, 21:271-279
Published Date: 13 February 2025
The Effects of Hyperlipidemia on Postoperative Cognitive Dysfunction in Patients Undergoing Laparoscopic Gynecological Tumor Surgery
Shen H, Xiong Y, Liang Y, Liu Z, Guo L, Qin Y, He J, Lin F
Neuropsychiatric Disease and Treatment 2025, 21:259-269
Published Date: 13 February 2025
Propionic Acid-Producing Bacteria as Provocateurs of Anxiety and Depression? [Letter]
Prescott SL, Logan AC
Neuropsychiatric Disease and Treatment 2025, 21:257-258
Published Date: 6 February 2025
The Prevalence of Depression Among Parkinson’s Disease Patients in Saudi Arabia: A Cross-Sectional Study
Al-Qahtani Z, Alqahtani ASM, Alzuhairi AMS, Qarah M, Alqarni AA, Alqahtani AOM, AlShehri FAA, Alqathanin MAA, Alshahrani OMO, Alqahtani MAF, Mahmood SE
Neuropsychiatric Disease and Treatment 2025, 21:241-256
Published Date: 4 February 2025
Factors Affecting Negative Symptoms in Schizophrenia and Their Relationship with Anxiety and Depression
Zeng G, Liang R, Xiao L, Cao W, Zhou W, Wang W, Liu C, Zhou H, Shi X, Chen B, Chen W
Neuropsychiatric Disease and Treatment 2025, 21:229-240
Published Date: 4 February 2025
Characteristics of Parthenogenetic Stem Cells and Their Potential Treatment Strategy for Central Nervous System Diseases
Cai H, Huang J, Wang W, Lin W, Ahmed W, Lu D, Quan J, Chen L
Neuropsychiatric Disease and Treatment 2025, 21:213-227
Published Date: 3 February 2025
Research Progress on Neural Processing of Hand and Forearm Tactile Sensation: A Review Based on fMRI Research
Chen H, Fu S, Zhi X, Wang Y, Liu F, Li Y, Ren F, Zhang J, Ren L, Wang Y
Neuropsychiatric Disease and Treatment 2025, 21:193-212
Published Date: 31 January 2025
Social Anxiety Symptoms in The Visually Impaired Versus Healthy Control: Saudi Arabian Samples
Alsubaie SS
Neuropsychiatric Disease and Treatment 2025, 21:185-191
Published Date: 31 January 2025
Insufficient Evidence to Recommend Shu Mian Capsule in Managing Depression With or Without Comorbid Insomnia: A Systematic Review With Meta-Analysis and Trial Sequential Analysis
Zhao FY, Xu P, Kennedy GA, Jin X, Wang YM, Zhang WJ, Yue LP, Ho YS, Fu QQ, Conduit R
Neuropsychiatric Disease and Treatment 2025, 21:167-183
Published Date: 31 January 2025
Differentiations in Illness Duration, Thyroid-Stimulating Hormone, Glucose and P300 Latency Between Drug-Naïve Unipolar and Bipolar Depression: A Comparative Cross-Sectional Study
Li C, Yang L, Zhang Q, Zhang Y, Li R, Jia F, Wang L, Ma X, Yao K, Tian H, Liu Z, Zhuo C
Neuropsychiatric Disease and Treatment 2025, 21:157-166
Published Date: 29 January 2025
Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
Kinderlehrer DA
Neuropsychiatric Disease and Treatment 2025, 21:141-155
Published Date: 29 January 2025
Predictive Value of NT-proBNP for Functional Outcome of Ischemic Stroke Without Cardiac Disease: A Prospective, Observational Study
Liu R, Chen G, Zhao N, Yue W
Neuropsychiatric Disease and Treatment 2025, 21:129-140
Published Date: 27 January 2025
Functional Remediation Improves Serum BDNF and TrkB Levels in Euthymic Patients with Bipolar Disorder: A Randomized Trial Study
Li R, Li J, Ji SS, Li D, Chu L, Zhang J, Sun X, Luo X, Zhang Y
Neuropsychiatric Disease and Treatment 2025, 21:115-128
Published Date: 25 January 2025
White Matter Injury in Central Nervous System Disorders
Zheng L, Wang X, Li P, Hao Y, Zhang H, Chen H, Zheng Z
Neuropsychiatric Disease and Treatment 2025, 21:107-114
Published Date: 24 January 2025
Clinical Utility of Zuranolone for Postpartum Depression: A Narrative Review
Giannopoulos A, Singh J, Deligiannidis KM
Neuropsychiatric Disease and Treatment 2025, 21:93-105
Published Date: 25 January 2025
Multimodal Magnetic Resonance Findings in Parkinson’s Disease With “Antecedent Essential Tremor”: A Case Series of a Large Kindred
Kong Y, Yao L, Xiao X, Chen A, Wang K, Yan H, Sun R, Liu R, Kong Q
Neuropsychiatric Disease and Treatment 2025, 21:79-92
Published Date: 22 January 2025
A Systematic Review of Knowledge, Attitude, and Perception Towards Electroconvulsive Therapy (ECT) in Africa
Abaatyo J, Kaggwa MM
Neuropsychiatric Disease and Treatment 2025, 21:67-77
Published Date: 13 January 2025
Emerging Implications of Serum Resolvin D2 as a Biochemical Marker for Severity Assessment and Prognosis Prediction Following Moderate-Severe Traumatic Brain Injury: A Prospective Cohort Study
Zong H, Zong Y, Li J, Zhao S, Wu W, Chen R, Zhao G, Li Z
Neuropsychiatric Disease and Treatment 2025, 21:53-65
Published Date: 10 January 2025
Cognitive Disorders In Acquired Sensorineural Hearing Loss, At The Ent Department Of The “Village Bondeko” Center, In Kinshasa
Masamba GR, Sokolo Gedikondele J, Longo-Mbenza B, Nganga Nkanga MS, Matanda Nzanza R, Matonda-ma-Nzuzi T, Ikanga J, Nge Okwe A, Lema Mabwaka G, Mawalala Malengele H, Nangi Mampuya C, Lumbu Malundama D
Neuropsychiatric Disease and Treatment 2025, 21:37-52
Published Date: 7 January 2025
Relationship Between Anxiety Symptoms and Age-Related Differences in Tic Severity
Lei T, Yang K, Jun J, Hu S, Yang Q, Hong X, Cui Y
Neuropsychiatric Disease and Treatment 2025, 21:25-36
Published Date: 6 January 2025
The Association of Mitochondrial tRNACys G5783A Mutation with Major Depressive Disorder in Two Han Chinese Families
Jing P, Yu H, Sun W, Liang M, Xia T, Yang H, Chen P, Li J, Zhang X
Neuropsychiatric Disease and Treatment 2025, 21:15-24
Published Date: 3 January 2025
Negative Affect and Impulsivity in Adolescents with Non-Suicidal Self-Injury: The Moderating and Mediating Roles of Perceived Social Support
Pan B, Gong Y, Guo M, Wang X, Lu H, Lin Z, Zhang B
Neuropsychiatric Disease and Treatment 2025, 21:1-13
Published Date: 1 January 2025